Christina Dorismond

Christina Dorismond

Auto-generated profile, based on publicly available information

Christina Dorismond

Department of Otolaryngology—Head and Neck Surgery Vanderbilt University Medical Center Nashville Tennessee USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2025 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
CDChristina Dorismond
Christina Dorismond
YTYash Trivedi
Yash Trivedi
MKMason R. Krysinski
Mason R. Krysinski
RLRory J. Lubner
Rory J. Lubner
LHLi-Ching Huang
Li-Ching Huang
JTJustin H. Turner
Justin H. Turner
While phenotypic features have traditionally guided treatment in chronic rhinosinusitis (CRS), recent research has favored categorization based on inflammatory endotype. However, the impact of endotypic differences on clinical outcomes remains largely unknown. We aimed to compare disease trajectory, primarily time-to-polyp recurrence, between CRS with nasal polyp (CRSwNP) endotypes. Samples were obtained from CRSwNP patients undergoing surgery between 2015-2023, and cytokine levels were measured using a multiplex bead assay. Principal component analysis followed by hierarchical cluster analysis was used to identify endotype clusters. Clinical outcomes were subsequently compared between clusters RESULTS: We identified 6 CRSwNP disease clusters among the 269 included patients. Cluster 1 (46.5%) was characterized by relatively low inflammation. Clusters 4 (13.3%) and 6 (7.1%) also exhibited low inflammation but with elevated levels of interleukin (IL)-12/IL-21 and CCL5, respectively. Cluster 2 (4.5%) represented a mixed type 1/3 inflammatory endotype (IFN-γHigh/IL-4High/IL-17AHigh), and Cluster 3 (10.0%) was characterized by an innate, proinflammatory response (IL-1βHigh/IL-6High/IL-8High). Cluster 5 (18.9%) exhibited type 2 dominant inflammation (IL-5High/IL-9High/IL-13High). When comparing disease trajectory, Cluster 2 (IFN-γHigh/IL-4High/IL-17AHigh) and 4 (IL-12High/IL-21High) had the shortest time-to-polyp recurrence, while Cluster 3 (IL-1βHigh/IL-6High/IL-8High) demonstrated the longest time-to-recurrence (p<0.001). Time-to-oral steroids (p=0.13) and time-to-biologic therapy (p=0.43) were similar across clusters CONCLUSION: Our study highlights the heterogenous nature of CRSwNP and differences in disease trajectory between endotypes, notably that patients with mixed type 1 and 3 inflammation demonstrate more recalcitrant disease. These findings suggest that therapies beyond traditional type 2 inflammation treatments may be needed to effectively reduce CRSwNP disease recurrence.

10 October 2023 in Otology & Neurotology
Verified
Journal Article
Closed access
CDChristina Dorismond
Christina Dorismond
APAnkita Patro
Ankita Patro
JHJourdan T. Holder
Jourdan T. Holder
EPElizabeth L. Perkins
Elizabeth L. Perkins
Objective: To study the relationship between Cochlear Implant Quality of Life-10 Global (CIQOL-10) scores and speech recognition scores 6 and 12 months after cochlear implantation (CI) and to compare CIQOL-10 scores for patients who met the benchmark speech recognition scores with those who did not. Study Design: Retrospective review. Setting: Tertiary referral center. Patients: One hundred twenty-four adults who underwent CI between 2018 and 2021 and completed a CIQOL-10 questionnaire at their 6- and/or 12-month postoperative visit. Main Outcome Measure(s): CIQOL-10, Consonant-Nucleus-Consonant (CNC) word, and AzBio in quiet and noise scores. Results: At 6 months, weak positive correlations were found between CIQOL-10 and CNC (n = 78, r = 0.234, p = 0.039) and AzBio in quiet (n = 73, r = 0.293, p = 0.012) scores but not AzBio in noise scores (n = 39, r = 0.207, p = 0.206). At 12 months, weak positive correlations were found between CIQOL-10 and CNC (n = 98, r = 0.315, p = 0.002), AzBio in quiet (n = 88, r = 0.271, p = 0.011), and AzBio in noise (n = 48, r = 0.291, p = 0.045) scores. Patients who met the benchmark CNC scores had notably higher CIQOL-10 scores than those who did not at 6 months (52.0 vs 45.5, p = 0.008) and 12 months (52.0 vs 45.5, p = 0.003). A similar relationship was found for those who met the benchmark AzBio in quiet scores at both 6 months (52.0 vs 44.0, p = 0.006) and 12 months (52.0 vs 46.5, p = 0.011). Conclusion: CIQOL-10 scores have weak positive correlations with postoperative speech recognition outcomes at 6 and 12 months. This highlights the need for the continued use of quality-of-life measures, such as the CIQOL-10, in assessing CI outcomes to gain a more comprehensive understanding of patients' experiences.

18 March 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CDChristina Dorismond
Christina Dorismond
RSRupali N. Shah
Rupali N. Shah
CECharles S. Ebert
Charles S. Ebert
RBRobert A. Buckmire
Robert A. Buckmire

13 November 2024 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
CDChristina Dorismond
Christina Dorismond
MKMason R. Krysinski
Mason R. Krysinski
YTYash Trivedi
Yash Trivedi
RLRory J. Lubner
Rory J. Lubner
RCRakesh K. Chandra
Rakesh K. Chandra
JTJustin H. Turner
Justin H. Turner

1 January 2021 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
CDChristina Dorismond
Christina Dorismond
ZFZainab Farzal
Zainab Farzal
NTNicholas J. Thompson
Nicholas J. Thompson
SLSaangyoung E. Lee
Saangyoung E. Lee
CZCarlton J. Zdanski
Carlton J. Zdanski

12 April 2024 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
CDChristina Dorismond
Christina Dorismond
MSMiriam R. Smetak
Miriam R. Smetak
EPElizabeth L. Perkins
Elizabeth L. Perkins
AFAlexandra M. Foust
Alexandra M. Foust
ASAsha Sarma
Asha Sarma
FVFrank W. Virgin
Frank W. Virgin
Objective: Cochlear nerve deficiency (CND) is a common radiologic finding among unilateral sensorineural hearing loss (USNHL) patients. It is generally detected with magnetic resonance imaging (MRI), which is associated with higher cost, less availability, and possible need for sedation. Therefore, identifying computed tomography (CT) findings, such as cochlear aperture stenosis (CAS), that can reliably predict CND is valuable. Our study aimed to determine the prevalence of CND in pediatric patients with CT‐diagnosed CAS.Study Design: Retrospective study.Setting: Tertiary care center.Methods: We included pediatric patients diagnosed with CAS on temporal bone CT and with available temporal bone MRI. For each patient, an otolaryngologist and a pediatric neuroradiologist measured the cochlear aperture width on CT to confirm CAS (cochlear aperture < 1.4 mm) and assessed the status of the cochlear nerve on MRI.Results: Fifty‐five patients, representing 65 ears, had CAS on CT measurement. Median cochlear aperture width in CAS ears was 0.70 mm (interquartile range [IQR]: 0.40‐1.05 mm) versus 2.00 mm in non‐CAS ears (IQR: 1.80‐2.30 mm, P < .001). CND was found in 98.5% (n = 64/65) of CAS ears, while a normal cochlear nerve was found in 1.5% (n = 1/65) of CAS ears.Conclusion: CND is highly prevalent among pediatric patients with CAS. This suggests that MRI may not be needed to assess for CND in USNHL patients with CAS, as initial CT may provide sufficient information to determine cochlear implant candidacy. We recommend thoughtful shared decision‐making with parents of USNHL patients when determining whether to pursue MRI in the setting of a CAS diagnosis.